Upload Records Snowball Search Search OpenAlex
About the database ScholarIQanswers from OpenAlex
Sustained benefits of infliximab therapy for dermatologic and articular manifestations of psoriatic arthritis: Results from the infliximab multinational psoriatic arthritis controlled trial (IMPACT)
PaperCitations, authors & open-access status
Sustained benefits of infliximab therapy for dermatologic and articular manifestations of psoriatic arthritis: Results from the infliximab multinational psoriatic arthritis controlled trial (IMPACT) is a paper indexed in ScholarIQ from OpenAlex. ScholarIQ records 644 citations, 2005 year and closed oa status.
644
Citations
2005
Year
closed
OA Status